A Modular Approach to Obtain HER2-Targeting DM1-Loaded Nanoparticles for Gastric Cancer Therapy DOI Creative Commons
Hui Zhang,

Lijiao Guo,

Xue Li

и другие.

ACS Omega, Год журнала: 2024, Номер 9(49), С. 48598 - 48606

Опубликована: Ноя. 22, 2024

Antibody-based tumor-targeting nanomedicines, despite their high efficacy, present significant challenges in preparation and long-term storage. We introduce a novel approach for the synthesis of durable, ready-to-use, antibody-coupled nanomedical drugs. Our research centers on development HER2-targeting DM1-loaded nanoparticles gastric cancer treatment using modular methodology. synthesized Fc-PLG-Mal, conjugated DM1 through "click" reaction, subsequently bound resultant compound with HER2 antibody trastuzumab. The demonstrated drug loading content, stable particle size, effective targeting. HER2-PLG-DM1 exhibited cytotoxicity against NCI-N87 cells, an IC50 0.35 nM. Biodistribution revealed rapid substantial tumor accumulation, 6-fold higher than that nontargeting IgG-PLG-DM1. significantly inhibited growth tumor-bearing mice, achieving 90.8% inhibition rate, displayed dose-dependent effects without liver kidney toxicity. These studies offer efficient method

Язык: Английский

For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy DOI Creative Commons

Soroush Karimi,

Roksana Bakhshali,

Soheil Bolandi

и другие.

Materials Today Bio, Год журнала: 2025, Номер 31, С. 101626 - 101626

Опубликована: Март 1, 2025

Cancer treatment is challenged by the tumor microenvironment (TME), which promotes drug resistance and cancer cell growth. This review offers a comprehensive innovative perspective on how nanomedicine can modify TME to enhance therapy. Strategies include using nanoparticles improve oxygenation, adjust acidity, alter extracellular matrix, making treatments more effective. Additionally, immune responses activating cells reducing suppression within tumors. By integrating these approaches with existing therapies, such as chemotherapy radiotherapy, show promise in overcoming traditional barriers. The discusses changes effectiveness of itself, creating reciprocal relationship that boosts overall efficacy. We also highlight novel strategies aimed at exploiting TME, leveraging nanoparticle-based for targeted therapy through precise modulation.

Язык: Английский

Процитировано

2

Cascade Carrier‐Free Nanoparticles Forming In Situ Nanovaccines for Synergistic Photothermal‐Immunotherapy of Cancer DOI
Chenlu Huang, Hanyong Wang, Xinyu Yang

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(29)

Опубликована: Апрель 5, 2024

Abstract Rapid advances in nanotechnology have made it possible to combine photothermal therapy (PTT) with immunotherapy, enabling activate an situ vaccine effect. However, this effect is severely impeded by low antigen presentation level and highly suppressive tumor immune microenvironment (immune “cold” tumors). To overcome the obstacles, multifunctional carrier‐free nanoparticles (FCDP‐NPs) assembled from Fe 2+ , toll‐like receptor 9 agonist (CpG), cationic lipid (DOTAP) agent polydopamine are developed. After intratumoral injection, FCDP‐NPs carrying positive charge exposed under laser irradiation, which can capture tumor‐associated antigens (TAAs) generated upon post‐PTT form nanovaccines (FCD‐NPs@TAAs). The further promote cross‐presentation of TAAs, stimulate adaptive responses, shape “hot” tumors. As a result, improve survival rates elicit durable memory that remarkedly prevents metastasis, illustrating useful platform for PTT synergized immunotherapy.

Язык: Английский

Процитировано

15

A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency DOI
Liyan Yang, Yingying Zhang,

Yuxin Lai

и другие.

Journal of Colloid and Interface Science, Год журнала: 2024, Номер 677, С. 523 - 540

Опубликована: Авг. 14, 2024

Язык: Английский

Процитировано

7

Carrier-Free Nanodrugs: From Bench to Bedside DOI

Fang Fang,

Xiaoyuan Chen

ACS Nano, Год журнала: 2024, Номер 18(35), С. 23827 - 23841

Опубликована: Авг. 20, 2024

Carrier-free nanodrugs with extraordinary active pharmaceutical ingredient (API) loading (even 100%), avoidable carrier-induced toxicity, and simple synthetic procedures are considered as one of the most promising candidates for disease theranostics. Substantial studies commercial success "carrier-free" nanocrystals have demonstrated their strong clinical potential. However, practical translations remain challenging impeded by unpredictable assembly processes, insufficient delivery efficiency, an unclear in vivo fate. In this Perspective, we systematically outline contemporary emerging carrier-free based on diverse APIs, well highlight opportunities challenges translation. Looking ahead, further improvements design preparation, drug delivery, efficacy, safety nanomedicines essential to facilitate translation from bench bedside.

Язык: Английский

Процитировано

7

Reinforcing Carrier‐Free Photothermal Nanodrugs Through Flavonol‐Driven Assembly DOI
Mingyu Fan, Xian Zheng,

Wenyu Cheng

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(37)

Опубликована: Май 15, 2024

Abstract Carrier‐free nanodrugs that integrate chemodrugs and other therapeutic agents demonstrate good efficacy minimized side effects, showing promise for combined therapy. However, a key challenge lies in enhancing the bioavailability potential of through controllable assembly process. Herein, carrier‐free photothermal nanodrug (ZPQ NPs) is constructed flavonol‐driven with amine‐substituted perylene diimide enhanced chemo‐photothermal cancer The flavonol, particularly quercetin, facilitates J‐aggregation derivatives within contributes to multiple improvements, including red‐shifted absorption, fluorescence intensity, improved conversion efficiency as well excellent photostability. Moreover, also demonstrates cellular uptake intracellular reactive oxygen species scavenging capability. combination quercetin effect effectively kills cells, alleviates inflammation following Guided by vivo imaging, application ZPQ NPs results complete tumor elimination inhibits recurrence This work presents straightforward strategy constructing exhibit simultaneous enhancements both photophysical properties biological activity.

Язык: Английский

Процитировано

6

Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway DOI Creative Commons
Yuanyuan Zhang,

Weiwei Jin,

Zhichao Deng

и другие.

Acta Pharmaceutica Sinica B, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Natural Polyphenol Delivered Methylprednisolone Achieve Targeted Enrichment for Acute Spinal Cord Injury Therapy DOI Open Access
Taoyang Yuan, Weijie Liu, Tianyou Wang

и другие.

Small, Год журнала: 2024, Номер 20(46)

Опубликована: Авг. 6, 2024

Abstract The strong anti‐inflammatory effect of methylprednisolone (MP) is a necessary treatment for various severe cases including acute spinal cord injury (SCI). However, concerns have been raised regarding adverse effects from MP, which also severely limits its clinical application. Natural polyphenols, due to their rich phenolic hydroxyl chemical properties, can form dynamic structures without additional modification, achieving targeted enrichment and drug release at the disease lesion, making them highly promising carrier. Considering application challenges natural polyphenolic platform employed efficient delivery reducing systemic side effects. Both in vitro SCI models demonstrated polyphenols multiple advantages as carriers delivering MP: (1) Achieved maximum injured site 2 h post‐administration, met desires early diseases; (2) Traceless MP; (3) Reducing effects; (4) Endowed system with new antioxidative an aspect that needs be addressed diseases treatment. This study highlighted prospect robust based on successfully overcome barrier MP treatment, providing possibility widespread

Язык: Английский

Процитировано

3

Dual‐Responsive Shape‐Transformable Charge‐Reversible Nanoparticles Combined with Chemo‐Photodynamic‐Immunotherapy for the Treatment of Breast Cancer and Lung Metastasis DOI

Wenfeng Jia,

Bokai Gong,

Jiantao Chen

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(48)

Опубликована: Июль 1, 2024

Abstract Herein, a dual‐responsive shape‐transforming charge‐reversal integrated nanomedicine system (DHP@BPP) is developed for the co‐delivery of photosensitizer pyro pheophorbide‐α (Ppa), anti‐programmed cell death ligand 1 (PD‐L1) peptide (dPPA), and tumor‐associated macrophages (TAMs)‐regulating drug berberrubine (BBR). Hydrophobic Ppa hydrophilic BBR are linked by matrix metalloproteinase‐2 (MMP‐2) responsive (PMGMRKLVFF) to form BPP. BPP can self‐assemble into spherical nanoparticles with positive charge, which undergo shape transformation nanofibers upon cleavage MMP‐2 at tumor sites. The dPPA conjugated hexa‐histidine polyethylene glycol DHP, then electrostatically adsorbed onto surface DHP@BPP negative charge. DHP not only enhances tumor‐targeting but also induces disassociation charge reversal due protonation histidine site, thereby increasing penetration while maintaining long blood circulation. Most importantly, through combination chemo‐photodynamic‐immunotherapy, it repolarize TAMs from M2‐type M1‐type reducing PD‐L1 expression reshape immunosuppressive microenvironment, synergistically enhancing effect immunogenic death. In conclusion, this study offered simple effective idea treatment cancers reversal, integrating chemo‐photodynamic‐immunotherapy.

Язык: Английский

Процитировано

2

Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy DOI
M. Zhang, Yifan Zhao,

Bai Lv

и другие.

ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(36), С. 47270 - 47283

Опубликована: Авг. 27, 2024

In situ vaccines that can stimulate tumor immune response have emerged as a breakthrough in antitumor therapy. However, the immunosuppressed microenvironment and insufficient infiltration of cells lead to ineffective immunity. Hence, biomimetic carrier-free nanosystem (BCC) induce synergistic phototherapy/chemotherapy-driven was designed. A developed using phototherapeutic reagents CyI celastrol raw materials. vitro vivo studies shown under NIR light irradiation, BCC-mediated photo/chemotherapy not only accelerates release drugs deeper parts tumors, achieving timing light-controlled drug delivery result cell apoptosis, but also effectively stimulates vaccine, which could invoke long-lasting immunity inhibit metastasis eliminate distant tumor. This therapeutic strategy holds promise for priming robust innate adaptive responses, arresting cancer progression, inducing dormancy.

Язык: Английский

Процитировано

1

A Modular Approach to Obtain HER2-Targeting DM1-Loaded Nanoparticles for Gastric Cancer Therapy DOI Creative Commons
Hui Zhang,

Lijiao Guo,

Xue Li

и другие.

ACS Omega, Год журнала: 2024, Номер 9(49), С. 48598 - 48606

Опубликована: Ноя. 22, 2024

Antibody-based tumor-targeting nanomedicines, despite their high efficacy, present significant challenges in preparation and long-term storage. We introduce a novel approach for the synthesis of durable, ready-to-use, antibody-coupled nanomedical drugs. Our research centers on development HER2-targeting DM1-loaded nanoparticles gastric cancer treatment using modular methodology. synthesized Fc-PLG-Mal, conjugated DM1 through "click" reaction, subsequently bound resultant compound with HER2 antibody trastuzumab. The demonstrated drug loading content, stable particle size, effective targeting. HER2-PLG-DM1 exhibited cytotoxicity against NCI-N87 cells, an IC50 0.35 nM. Biodistribution revealed rapid substantial tumor accumulation, 6-fold higher than that nontargeting IgG-PLG-DM1. significantly inhibited growth tumor-bearing mice, achieving 90.8% inhibition rate, displayed dose-dependent effects without liver kidney toxicity. These studies offer efficient method

Язык: Английский

Процитировано

0